2004/696/EC: Commission Decision of 14 October 2004 on the list of programmes for the eradication and the monitoring of certain TSEs qualifying for a financial contribution from the Community in 2005 (notified under document number C(2004) 4011)
1. The programmes for the monitoring of TSE (BSE and scrapie) listed in Annex I shall qualify for a financial contribution from the Community in 2005.
2. For each programme as referred to in paragraph 1, the proposed rate and maximum amount of the financial contribution from the Community shall be as set out in Annex I.
1. The programmes for the eradication of BSE listed in Annex II shall qualify for a financial contribution from the Community in 2005.
2. For each programme as referred to in paragraph 1, the proposed rate and maximum amount of the financial contribution from the Community shall be as set out in Annex II.
1. The programmes for the eradication of scrapie listed in Annex III shall qualify for a financial contribution from the Community in 2005.
2. For each programme as referred to in paragraph 1, the proposed rate and maximum amount of the financial contribution from the Community shall be as set out in Annex III.
This Decision is addressed to the Member States.
Supplementary provisions
ANNEX ISupplementary provisions
ANNEX I
List of programmes for the monitoring of TSEs
Rate and maximum amount of the Community financial contribution
(in EUR)
Disease
Member State
Rate rapid tests performed
Maximum
TSEs
Austria
100 %
1 920 000
Belgium
100 %
3 550 000
Cyprus
100 %
85 000
Czech Republic
100 %
1 700 000
Denmark
100 %
2 375 000
Estonia
100 %
290 000
Finland
100 %
1 160 000
France
100 %
24 045 000
Germany
100 %
15 020 000
Greece
100 %
585 000
Hungary
100 %
1 085 000
Ireland
100 %
6 170 000
Italy
100 %
6 660 000
Lithuania
100 %
835 000
Luxembourg
100 %
145 000
Malta
100 %
35 000
Netherlands
100 %
4 270 000
Portugal
100 %
1 135 000
Slovenia
100 %
435 000
Spain
100 %
4 780 000
Sweden
100 %
305 000
United Kingdom
100 %
5 570 000
Total
82 155 000
ANNEX IISupplementary provisions
ANNEX II
List of programmes for the eradication of BSE
Maximum amount of the Community financial contribution
(in EUR)
Disease
Member State
Rate
Maximum amount
BSE
Austria
50 % culling
10 000
Belgium
50 % culling
250 000
Cyprus
50 % culling
25 000
Czech Republic
50 % culling
2 500 000
Denmark
50 % culling
200 000
Estonia
50 % culling
25 000
Finland
50 % culling
25 000
France
50 % culling
500 000
Germany
50 % culling
875 000
Greece
50 % culling
150 000
Ireland
50 % culling
4 000 000
Italy
50 % culling
205 000
Luxembourg
50 % culling
150 000
Netherlands
50 % culling
450 000
Portugal
50 % culling
975 000
Slovak Republic
50 % culling
25 000
Slovenia
50 % culling
25 000
Spain
50 % culling
1 320 000
United Kingdom
50 % culling
4 235 000
Total
15 945 000
ANNEX IIISupplementary provisions
ANNEX III
List of programmes for the eradication of scrapie
Maximum amount of the Community financial contribution
(in EUR)
Disease
Member State
Rate
Maximum amount
Scrapie
Austria
50 % culling; 100 % genotyping
10 000
Belgium
50 % culling; 100 % genotyping
105 000
Cyprus
50 % culling; 100 % genotyping
5 565 000
Czech Republic
50 % culling; 100 % genotyping
20 000
Denmark
50 % culling; 100 % genotyping
5 000
Estonia
50 % culling; 100 % genotyping
10 000
Finland
50 % culling; 100 % genotyping
5 000
France
50 % culling; 100 % genotyping
1 300 000
Germany
50 % culling; 100 % genotyping
2 275 000
Greece
50 % culling; 100 % genotyping
1 555 000
Hungary
50 % culling; 100 % genotyping
5 000
Ireland
50 % culling; 100 % genotyping
800 000
Italy
50 % culling; 100 % genotyping
2 485 000
Latvia
50 % culling; 100 % genotyping
5 000
Lithuania
50 % culling; 100 % genotyping
5 000
Luxembourg
50 % culling; 100 % genotyping
35 000
Netherlands
50 % culling; 100 % genotyping
575 000
Portugal
50 % culling; 100 % genotyping
695 000
Slovak Republic
50 % culling; 100 % genotyping
340 000
Slovenia
50 % culling; 100 % genotyping
65 000
Spain
50 % culling; 100 % genotyping
9 525 000
Sweden
50 % culling; 100 % genotyping
10 000
United Kingdom
50 % culling; 100 % genotyping
7 380 000
Total
32 775 000
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.